Optimal time for pharmacological treatment of abdominal aortic aneurysm

Y Iida, S Sawa, H Shimizu - Current drug targets, 2018 - ingentaconnect.com
Background: Abdominal aortic aneurysm (AAA), if left untreated, poses the main risks of
progressive expansion, rupture, and hemorrhage, leading to death. Large AAA with a risk of …
被引用次数：3 相关文章

Optimal time for pharmacological treatment of abdominal aortic aneurysm

Y Iida, S Sawa, H Shimizu - Current drug targets, 2018 - keio.elsevierpure.com
Background: Abdominal aortic aneurysm (AAA), if left untreated, poses the main risks of
progressive expansion, rupture, and hemorrhage, leading to death. Large AAA with a risk of …

Optimal Time for Pharmacological Treatment of Abdominal Aortic Aneurysm

Y Iida, S Sawa, H Shimizu - Current drug targets, 2018 - pubmed.ncbi.nlm.nih.gov
Background Abdominal aortic aneurysm (AAA), if left untreated, poses the main risks of
progressive expansion, rupture, and hemorrhage, leading to death. Large AAA with a risk of …

Optimal Time for Pharmacological Treatment of Abdominal Aortic Aneurysm.

Y Iida, S Sawa, H Shimizu - Current Drug Targets, 2018 - europepmc.org
Background Abdominal aortic aneurysm (AAA), if left untreated, poses the main risks of
progressive expansion, rupture, and hemorrhage, leading to death. Large AAA with a risk of …

[引用][C] Optimal Time for Pharmacological Treatment of Abdominal Aortic Aneurysm

Y Iida, S Sawa, H Shimizu - Current Drug Targets, 2018 - cir.nii.ac.jp
Optimal Time for Pharmacological Treatment of Abdominal Aortic Aneurysm | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Optimal time for pharmacological treatment of abdominal aortic aneurysm

Y Iida, S Sawa, H Shimizu - Current drug targets, 2018 - keio.elsevierpure.com
Background: Abdominal aortic aneurysm (AAA), if left untreated, poses the main risks of
progressive expansion, rupture, and hemorrhage, leading to death. Large AAA with a risk of …